Cardiff Oncology, Inc. (CRDF) insider buying and selling

NASDAQ: CRDF · Source: SEC Form 4 filings · Latest trade reported

There were no open-market insider purchases or sales at Cardiff Oncology, Inc. (CRDF) in the last 90 days. Over the last 12 months, 2 insiders bought $1.1M of the stock, led by GARY W PACE (Director), who bought $1000K on Jul 14, 2026.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
0
$0 · 0 insiders
Insider buys, 12 months
4
$1.1M · 2 insiders
Insider sales, 12 months
0
$0 · 0 insiders

This is the public summary. Create a free account to see CRDF’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock CRDF

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at Cardiff Oncology, Inc.
DateInsiderTypeSharesPriceValue
GARY W PACE
Director
Open market purchase687,285$1.46$1000K
Mani Mohindru
CEO
Open market purchase34,364$1.46$50K
GARY W PACE
Director
Open market purchase30,000$1.22$37K
Mani Mohindru
CEO
Open market purchase24,703$1.21$30K

What the CRDF insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for Cardiff Oncology, Inc. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with CRDF Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about CRDF insider trading

Who bought Cardiff Oncology, Inc. (CRDF) stock recently?

Insiders who bought Cardiff Oncology, Inc. stock on the open market in the last 12 months: GARY W PACE ($1.0M), Mani Mohindru ($80K). The most recent purchase was reported on Jul 14, 2026.

Are insiders buying or selling CRDF?

Over the last 12 months insiders were net buyers of CRDF on discretionary trades: $1.1M bought against $0 sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see CRDF in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.